Doctor profile · Federal record
Dr. MELISSA LEWIS, PA-C
Medical Physician Assistant (CMS: PHYSICIAN ASSISTANT) · GREENVILLE, NC
- NPI 1912979295
- Accepts Medicare
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1850 W ARLINGTON BLVD
GREENVILLE, NC 278345704
(252) 413-6683
fax (252) 830-0558
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- October 13, 2014
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- North Carolina #103633
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1912979295. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,852
Distinct HCPCS
10
Medicare allowed
$90,138
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,681 | 22 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 298 | 176 | $102 | |
83036 |
Hemoglobin a1c level | 264 | 153 | $9 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 229 | 135 | $3 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 99 | 61 | $28 | |
99457 |
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 60 | 16 | $38 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 52 | 44 | $144 | |
99458 |
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 37 | 13 | $32 | |
96372 |
Injection of drug or substance under skin or into muscle | 35 | 23 | $11 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 32 | 32 | $72 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 88. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$159
Transactions
8
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 3 | $59.68 | |
| Novo Nordisk Inc | 2 | $37.09 | |
| Medtronic, Inc. | 1 | $28.93 | |
| Corcept Therapeutics | 1 | $18.17 | |
| Dexcom, Inc. | 1 | $14.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,774
Patients
599
Total drug cost
$2,078,842
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 555 | 99 | $645,270 |
| Levothyroxine Sodium | Generic | 255 | 58 | $3,375 |
| Trulicity (Dulaglutide) | Brand | 210 | 34 | $262,850 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 201 | 48 | $184,425 |
| Synthroid (Levothyroxine Sodium) | Brand | 197 | 40 | $17,875 |
| Jardiance (Empagliflozin) | Brand | 195 | 45 | $177,489 |
| Metformin Hcl | Generic | 181 | 44 | $2,525 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 164 | 29 | $1,488 |
| Novolog Flexpen (Insulin Aspart) | Brand | 161 | 44 | $248,319 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 145 | 38 | $113,248 |